Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NewMedical Technology is a specialized medical device company focused on the development and distribution of advanced scar management solutions. The company is best known for its NewGel+ and MyNewGel product lines, which utilize medical-grade silicone technology to treat and prevent hypertrophic and keloid scars. Their portfolio includes a variety of silicone gel sheets, strips, and topical gels tailored for different anatomical locations and surgical procedures. These products are widely recommended by plastic surgeons and dermatologists to improve the appearance of scars resulting from surgery, trauma, or burns. Headquartered in Illinois, the company serves both professional medical markets and direct-to-consumer channels globally. NewMedical Technology maintains high quality standards, including ISO 13485 certification for its manufacturing processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MyNewGel.